Foghorn Therapeutics

0 followers


Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Their proprietary Gene Traffic Control platform gives them an integ... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

Adrian Gottschalk
President & CEO

Adrian Gottschalk

Collapse
Samuel Agresta
Chief Medical Officer
Michael Lacascia
Chief Legal Officer
Steven Bellon
Chief Scientific Officer
Fanny Cavalié
Chief Strategy & Business Operations Officer
Carlos Costa
Chief People Officer
Jacqueline Cinicola
VP, Regulatory Affairs
Chong-Hui Gu
VP, CMC & QA
Murphy Hentemann
VP, Program Leadership
Scott Innis
VP, Program Leadership
Ben Strain
VP, Investor Relations & Corporate Communications
Danette L. Daniels
VP, Protein Degrader Platform
Kevin Wilson
VP, Chemistry
Marina Nelen
VP, Drug Discovery
Gromek Smolen
VP, Biology
Karin Hellsvik
VP, Corporate Affairs
Saurabh Sewak
VP, Corporate Development
Dan Dinu
VP, Information Technology